Comparing different machine learning models for HIV whole cell and reverse transcriptase
What is it about?
We curated select whole cell and reverse transcriptase datasets from the NIAID ChemDB database and used these with other datasets to build and validate machine learning methods (deep learning, bayesian, support vector machines etc.). We performed 5 fold cross validation and external validation with different test sets.
Why is it important?
We describe how there is really not a huge difference between different machine learning methods. We also describe a new metric that can be used to summarize many different model scores. We demonstrate how Assay Central Bayesian models may be a useful starting point for drug discovery efforts.
The following have contributed to this page: Dr Sean Ekins